Compare Mesoblast Limited (MESO) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs NIO Inc. — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while NIO Inc. trades at $4.57 (market cap $11.59B). The key difference: NIO Inc. is far larger — about 5.2× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| MESO | NIO | |
|---|---|---|
Market Cap | $2.21B | $11.59B |
Sector | Technology | Consumer Cyclical |
52-Week High | $20.96 | $7.89 |
52-Week Low | $12.88 | $4.44 |
Enterprise Value | $2.21B | $10.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
